Global Oncology Biomarkers & Precision Medicine Lead

Bristol-Myers Squibb Co; Princeton (NJ); On-site; USD 216,000 - 261,000; Full time

Job summary

Bristol Myers Squibb in Princeton, NJ seeks a Senior Director of Global Commercial Strategy Oncology – Precision Medicine to lead biomarker and diagnostic commercialization across solid tumor and hematology assets. You will shape strategy from discovery to launch, ensure CDx readiness, and drive access and payer considerations to enable patient impact.

You will partner with GPTs, Tumor Leads, Diagnostics Development, Medical, Market Access, and regional teams to build end-to-end franchise plans,

Qualifications

• BS degree in business, life sciences, or related field, advanced degree (MBA, PhD, PharmD) preferred.
• Minimum 12 years of experience in oncology commercial strategy, marketing, diagnostics, or related roles within the pharmaceutical/biotech/diagnostics industry, including significant global commercial strategy experience.
• Proven ability to lead cross-functional teams and influence senior stakeholders in a matrixed global environment.
• Deep understanding of the oncology market landscape, including solid tumors and hematology, and of the precision medicine and companion diagnostic ecosystem.
• Demonstrated experience with US and global drug and CDx launches, and with early asset and new product development.
• Strong analytical, strategic planning, and communication skills.
• Experience in lifecycle management and business development is preferred; experience in diagnostics, laboratory, or commercial training and development is a plus.
• Strategic agility and commercial acumen
• Precision medicine and diagnostic launch excellence
• Cross-functional collaboration and matrix influence
• Results orientation and accountability
• Change leadership and adaptability
• Talent development and team leadership

Responsibilities

• Lead the development and execution of global precision medicine and diagnostic commercialization strategies across solid tumor and hematology assets, in alignment with overall oncology portfolio objectives.
• Drive global CDx readiness and launch excellence, including testing strategy, assay and platform selection, laboratory and ecosystem readiness, and payer and reimbursement considerations, to enable timely patient access and precision medicine adoption.
• Deliver strategic precision medicine insights, including biomarker prevalence, testing patterns, and competitive and market dynamics, that inform enterprise decision-making, investment choices, and portfolio value.
• Serve as a core member of Global Product Teams (GPTs) across relevant assets and participate early in drug development planning to shape biomarker and diagnostic strategy from first-in-human through launch.
• Partner closely with Tumor Leads, Development, Diagnostics Development, Medical, Market Access, Business Development, and regional and local commercial teams to drive integrated franchise plans and end-to-end accountability.
• Embed precision medicine strategies into BMS commercialization processes globally and locally, ensuring consistent execution and capability building across markets.
• Support launch readiness and lifecycle management for pipeline and in-line assets, including scenario planning and risk mitigation for biomarker-driven indications.
• Contribute to business development activities, including asset evaluation, diagnostic partnerships, and external collaborations with diagnostic and laboratory partners.
• Collaborate with Portfolio Strategy & Operations, Market Foresight, and Project Management teams to ensure operational excellence and cross-tumor alignment.
• Prepare and present business cases, strategic recommendations, and performance updates to senior leadership.
• Mentor and develop talent within the franchise, supporting succession planning and team capability building.

Skills

Cross-functional leadership

Strategic planning

Biomarker strategy

Diagnostics knowledge

Global launches

Communication skills

Education

BS degree in business, life sciences, or related field

MBA / PhD / PharmD preferred

Job description

Bristol Myers Squibb in Princeton, NJ seeks a Senior Director of Global Commercial Strategy Oncology – Precision Medicine to lead biomarker and diagnostic commercialization across solid tumor and hematology assets. You will shape strategy from discovery to launch, ensure CDx readiness, and drive access and payer considerations to enable patient impact.

You will partner with GPTs, Tumor Leads, Diagnostics Development, Medical, Market Access, and regional teams to build end-to-end franchise plans,